TCGX Announces Oversubscribed $600 Million Asia Fund
SHANGHAI & PALO ALTO, Calif.--(BUSINESS WIRE)-- #Biotechnology--TCGX today announced the closing of the TCGX Asia Life Sciences Fund I, an oversubscribed $600 million investment vehicle backed by a diverse group of international institutional investors. The fund will focus on investing in innovative biotechnology companies based in Asia. The fund is a new investment vehicle that will operate separately from, but in close synergy with, TCGX’s Flagship Funds, which focus on biotechnology companies in the United S